ArticleWorld journal of gastrointestinal oncology2017
Gastric xanthoma is a predictive marker for metachronous and synchronous gastric cancer.
Article in World journal of gastrointestinal oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 21 citations in OpenAlex.
- Gastric xanthelasma is a warning sign forFrontiers in medicine · 2023Article
- Adenoma arising from xanthoma in the transverse colon: a case report.Gastroenterology report · 2023Article
- Gastric Xanthelasma, Microsatellite Instability and Methylation of Tumor Suppressor Genes in the Gastric Mucosa: Correlation and Comparison as a Predictive Marker for the Development of Synchronous/Metachronous Gastric Cancer.Journal of clinical medicine · 2021Article
- Gastric Xanthoma Is Related to the Rapid Growth of Gastric Cancer.Journal of clinical medicine · 2021Article
- Gastric xanthoma is correlated with early gastric cancer of previouslyJGH open : an open access journal of gastroenterology and hepatology · 2021Article
- White globe appearance is an endoscopic predictive factor for synchronous multiple gastric cancer.Annals of gastroenterology · 2021Article
- Gastric Xanthoma Associated with Gastric Cancer Development: An Updated Review.Canadian journal of gastroenterology & hepatology · 2020Review
- Gastric Xanthoma in the Pediatric Population: A Possible Herald for Malignancy?Pediatric gastroenterology, hepatology & nutrition · 2020Article
- Gastric Xanthoma Is a Predictive Marker for Early Gastric Cancer Detected after Helicobacter pylori Eradication.Internal medicine (Tokyo, Japan) · 2019Observational
- Analysis of Risk Factors for Gastric Cancer and Precancerous Lesions: A Case-Control Study.Journal of digestive diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo investigate predictive markers for metachronous and synchronous gastric cancer (GC), which can develop after endoscopic submucosal dissection (ESD).
methodsA total of 352 patients underwent ESD for early GC at NTT West Osaka Hospital between June 2006 and February 2016. Exclusion criteria were as follows: Remnant stomach, unknown
resultsThe median age of Group B [72 years (interquartile range 63-78)] was significantly higher than that of Group A [66 years (interquartile range 61-74), respectively,
conclusionThe presence of GX is a useful predictive marker for metachronous and synchronous GC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.